Skip to main content

Recommended

Services

    PI Leaflets

      Pages

        No results found.

        Pathology tests database

        Back to Clinical Biochemistry

        Tobramycin

        Clinical Biochemistry

        Sample and container requirements

        Serum

        Minimum volume required

        Special requirements

        None

        Patient preparation

        See reference range for timing of sample collection.

        Sample viability

        Turnaround time

        2 days

        Reference range

        Multiple Daily Dosing: Pre dose (trough) blood sample 15 mins before dose: <2 mg/L Post dose (peak) blood sample 1 hour after dose: 5 – 10 mg/L NB: ranges and comments DO NOT apply to renal patients Once Daily Dosing: Pre dose (trough): <1 mg/L For diagnostic purposes, the test findings should always be assessed in conjunction with the patient’s medical history, clinical examinations, and other findings.

        Clinical guidance

        Tobramycin is an aminoglycoside broad-spectrum antibiotic that is excreted by the kidneys. It is considered to be a TDM: if levels are too high, it can permanently damage the kidneys and hearing. Toxicity is principally related to a high pre-dose level, as the drug is not being excreted effectively and is accumulating in the body. Tobramycin is used almost exclusively in cystic fibrosis and bronchiectasis patients, generally on a single daily dosing regimen. Please refer to LabTestsOnlineUK to learn more about therapeutic drug monitoring (TDM). https://labtestsonline.org.uk/tests/therapeutic-drug-monitoring

        Notes

        Images to go here

        This information was last updated on 19 August 2026